Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in Cancer Chemother Pharmacol

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    May 2018
  1. GAO C, Hu S, Guo M, Hai X, et al
    Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia.
    Cancer Chemother Pharmacol. 2018 May 29. pii: 10.1007/s00280-018-3606.
    PubMed     Text format     Abstract available


    January 2018
  2. KIM SY, Park JH, Yoon SY, Cho YH, et al
    A pilot study of daunorubicin-augmented hyper-CVAD induction chemotherapy for adults with acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2018 Jan 2. pii: 10.1007/s00280-017-3514.
    PubMed     Text format     Abstract available


    December 2017
  3. VOLLER S, Pichlmeier U, Zens A, Hempel G, et al
    Pharmacokinetics of recombinant asparaginase in children with acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2017 Dec 5. pii: 10.1007/s00280-017-3492.
    PubMed     Text format     Abstract available


    November 2017
  4. EMADI A, Law JY, Strovel ET, Lapidus RG, et al
    Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia.
    Cancer Chemother Pharmacol. 2017 Nov 8. doi: 10.1007/s00280-017-3459.
    PubMed     Text format     Abstract available


    October 2017
  5. MCATEE CL, Schneller N, Brackett J, Bernhardt MB, et al
    Treatment-related sinusoidal obstruction syndrome in children with de novo acute lymphoblastic leukemia during intensification.
    Cancer Chemother Pharmacol. 2017 Oct 19. doi: 10.1007/s00280-017-3453.
    PubMed     Text format     Abstract available


    August 2017
  6. BEN HASSINE I, Gharbi H, Soltani I, Ben Hadj Othman H, et al
    Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia.
    Cancer Chemother Pharmacol. 2017 Aug 23. doi: 10.1007/s00280-017-3424.
    PubMed     Text format     Abstract available


    June 2017
  7. DEHGHAN-NAYERI N, Eshghi P, Pour KG, Rezaei-Tavirani M, et al
    Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2017 Jun 5. doi: 10.1007/s00280-017-3347.
    PubMed     Text format     Abstract available


    May 2017
  8. MESRIAN TANHA H, Rahgozar S, Mojtabavi Naeini M
    ABCC4 functional SNP in the 3' splice acceptor site of exon 8 (G912T) is associated with unfavorable clinical outcome in children with acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2017 May 26. doi: 10.1007/s00280-017-3340.
    PubMed     Text format     Abstract available


    March 2017
  9. GALEOTTI L, Ceccherini F, Domingo D, Laurino M, et al
    Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia.
    Cancer Chemother Pharmacol. 2017 Mar 13. doi: 10.1007/s00280-017-3271.
    PubMed     Text format     Abstract available


  10. BEN HASSINE I, Gharbi H, Soltani I, Teber M, et al
    hOCT1 gene expression predict for optimal response to Imatinib in Tunisian patients with chronic myeloid leukemia.
    Cancer Chemother Pharmacol. 2017 Mar 12. doi: 10.1007/s00280-017-3266.
    PubMed     Text format     Abstract available


  11. LANVERS-KAMINSKY C
    Asparaginase pharmacology: challenges still to be faced.
    Cancer Chemother Pharmacol. 2017;79:439-450.
    PubMed     Text format     Abstract available


  12. YE YE, Woodward CN, Narasimhan NI
    Absorption, metabolism, and excretion of [14C]ponatinib after a single oral dose in humans.
    Cancer Chemother Pharmacol. 2017;79:507-518.
    PubMed     Text format     Abstract available


    October 2016
  13. VARATHARAJAN S, Panetta JC, Abraham A, Karathedath S, et al
    Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia.
    Cancer Chemother Pharmacol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  14. FORSTER VJ, van Delft FW, Baird SF, Mair S, et al
    Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients.
    Cancer Chemother Pharmacol. 2016.
    PubMed     Text format     Abstract available


  15. NIELSEN SN, Grell K, Nersting J, Frandsen TL, et al
    Measures of 6-mercaptopurine and methotrexate maintenance therapy intensity in childhood acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  16. KIM JH, Lee C, Cheong HS, Koh Y, et al
    SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia.
    Cancer Chemother Pharmacol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  17. OGURA M, Ishida T, Tsukasaki K, Takahashi T, et al
    Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
    Cancer Chemother Pharmacol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  18. DRENBERG CD, Buaboonnam J, Orwick SJ, Hu S, et al
    Evaluation of artemisinins for the treatment of acute myeloid leukemia.
    Cancer Chemother Pharmacol. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: